EPISODE · May 16, 2024 · 26 MIN
Risk Assessment of PSA Recurrent Prostate Cancer
from Cancer Frontiers (Audio) · host UCTV: UC San Francisco
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
Embed this episode
Ready to play
Risk Assessment of PSA Recurrent Prostate Cancer
0:00
26:55
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Cancer Frontiers (Audio)?
This episode is 26 minutes long.
When was this Cancer Frontiers (Audio) episode published?
This episode was published on May 16, 2024.
Can I download this Cancer Frontiers (Audio) episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!